Attached files

file filename
EX-32.1 - EX-32.1 - Xenon Pharmaceuticals Inc.xene-ex321_118.htm
EX-10.19 - EX-10.19 - Xenon Pharmaceuticals Inc.xene-ex1019_115.htm
EX-32.2 - EX-32.2 - Xenon Pharmaceuticals Inc.xene-ex322_119.htm
EX-31.2 - EX-31.2 - Xenon Pharmaceuticals Inc.xene-ex312_117.htm
EX-31.1 - EX-31.1 - Xenon Pharmaceuticals Inc.xene-ex311_116.htm
10-K - 10-K - Xenon Pharmaceuticals Inc.xene-10k_20151231.htm
EX-10.20 - EX-10.20 - Xenon Pharmaceuticals Inc.xene-ex1020_114.htm

 

 

 

EXHIBIT 23.1

 

 

KPMG LLP

Chartered Professional Accountants

PO Box 10426 777 Dunsmuir Street

Vancouver BC V7Y 1K3

Canada

Telephone

Fax

Internet

 

(604) 691-3000

(604) 691-3031

www.kpmg.ca

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors
Xenon Pharmaceuticals Inc.

We consent to the incorporation by reference in the registration statements on Form S-8 (Nos. 333-199860 and 333-202765) and Form S-3 (No. 333-208376) of Xenon Pharmaceuticals Inc. of our report dated March 8, 2016, with respect to the balance sheets of Xenon Pharmaceuticals Inc. as of December 31, 2015 and December 31, 2014, and the related  statements of operations and comprehensive income (loss), shareholders’ equity (deficit), and cash flows for each of the years in the three-year period ended December 31, 2015, which report appears in the December 31, 2015 annual report on Form 10-K of Xenon Pharmaceuticals Inc.

/s/ KPMG LLP

Chartered Professional Accountants

March 8, 2016
Vancouver, Canada

KPMG LLP is a Canadian limited liability partnership and a member firm of the KPMG
network of independent member firms affiliated with KPMG International Cooperative
(“KPMG International”), a Swiss entity.
KPMG Canada provides services to KPMG LLP.